Ovarian cancer clinical study results
Filed with ASX · · 2 pages · English
Earlier from Inoviq
- Appendix 4D and Half Yearly Reports and Accounts
- Successful Assay Feasibility Results
- Quarterly Activities Review and Appendix 4C
- Appointment of CEO
- Company Update - Promising Result for Ovarian Cancer
Later from Inoviq
- Cancer Vaccine Collaboration
- Lung Cancer Study Results
- Shareholder Update
- Australian Patent Issued
- Publication of BARD1 Lung Cancer Test
Follow Inoviq into a list and get an email when it puts out news.
Follow Inoviq